Franklin Lakes-based BD, a medical technology company, announced three executive appointments.
Alberto Mas has been named president of the medical segment, effective May 29. Before his appointment he was president of the life sciences segment for BD and before that served as president of three major business units including diagnostic systems, biosciences and medical surgical systems.
“Alberto is a proven leader who has excelled at every position he’s held at BD,” Tom Polen, president of BD, said. “He is the right leader for our largest segment, and I have full confidence he will continue to drive our growth and innovation strategy across the medical segment.”
Patrick Kaltenbach has been named president of the life sciences segment, replacing Mas, effective May 29. Before this, he was senior vice president of Agilent and president of the life sciences and applied markets group since 2014. He’s held various roles in research and development management and business leadership.
“Attracting an industry leader of Patrick’s caliber to BD is a testament to our life sciences strategy and the segment’s progress toward becoming a transformative partner from discovery to diagnosis,” Polen said. “Patrick brings a unique combination of deep experience and knowledge within the life sciences industry and a passion for creating value through innovation and technology. We are pleased to have his leadership as we continue to advance our life sciences segment.”
In addition, the company named Bill Tozzi as interim president of its interventional segment, effective May 1. Tozzi has been serving as the integration leader since April 2017.Before that, he was president of medication and procedural solutions.
“Bill is a seasoned BD executive with a strong track record of success and deep integration experience,” Polen said. “Together with the strong interventional segment leadership team driving the business, I am confident we are well positioned to fulfill our potential as a combined company.”
